The magazine for professional developers of consumer packaged goods
Updated on 07/11/2003
Home
Subscribe
Media pack (pdf)
Terms & conditions
Privacy statement
Contact us
Copyright © Gateway Publishing Ltd 2002-2005. All rights reserved.
STOP PRESS

Bayer to focus on health care, nutrition and innovative materials

German chemicals firm Bayer is to reorganise itself to develop and expand its core activities in health care, nutrition and innovative materials.

It will combine Bayer Chemicals (excluding HC Starck and Wolff Walsrode) with parts of the polymers business in a new company. “NewCo” will have sales of 5.6bn, 5000 products, and a staff of 20,000, making it a large European chemicals firm in its own right. Bayer Polymers boss Dr Axel Claus Heitmann will lead it to the stock market by early 2005.

Bayer CEO Werner Wenning said the split will enable Bayer, “with sales of around 22bn euros, to focus more closely on the core businesses in which we have excellent technologies, strong market positions and above all growth areas that we intend to further strengthen by pooling all our resources.

“Bayer aims to concentrate all its financial and management resources on developing and expanding its core activities in health care, nutrition and innovative materials, which are predominantly research-intensive areas.”

Bayer will have three operating subgroups: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. Growth will come mainly from products made with new active ingredients, from the consumer healthcare business and from growth in Asia. But it expects to extract more value from the group-wide use of technology platforms, nanotechnology and the expansion of biotechnology and genetic engineering as key innovation drivers.

Bayer's new realignment also includes repositioning the Pharmaceuticals business. The target areas are anti-infectives, cardiovascular (including diabetes and obesity) and urology. Bayer also has a number of promising product developments in the oncology (cancer) field. Europe will be its main market, but the US and Asia will not be neglected, Wenning says.

HEADLINE NEWS 07 November 2003

GM labels in force from April 2004
Grolsch swings to SIG
Bacteria clean waste water
European firms ignore patent information
Obesity training wasted on GPs
GSK in seventh R&D heaven
Barcodes to get reprieve?

Regulation

GM labels in force from April 2004

Food and beverage processors will have to conform to the European Union’s new rules on labelling genetically modified (GM) food from April 2004. US food exporters, especially maize farmers, have already condemned the move.

All foodstuffs that contain or consist of GM organisms, or contain ingredients produced from GMOs, will need to be labelled. A threshold of 0.9% will apply for the accidental presence of GM material, below which labelling of food or feed is not required. There will also be a 0.5% threshold for the presence of GM material that has not been approved for use in Europe, provided it has a favourable safety assessment from the European Union scientific committees. This threshold will apply for three years.

The regulations will not apply to food produced using GM processing aids, such as some cheeses, or products from animals fed GM animal feed.

Risk assessment of GM foods will be centralised through the European Food Safety Authority. Authorisation, if granted, will be for 10 years, after which companies will have to apply for it to be renewed.

The second of the European Commission's two GM regulations, on traceability and labelling, was also adopted and published at the same time. This regulation will provide a harmonised EU system on the documentation needed to trace GM products throughout the supply chain.

Business

Grolsch swings to SIG

Grolsch, the Dutch brewer famed for its swing-top bottles, has picked Italo-Swiss equipment supplied SIG Simonazzi to supply six filling lines for its new brewery, said to be currently the only greenfield brewhouse project in Europe.

Grolsch is a new customer for SIG Simonazzi, who combined with Danish engineering consultants Danbrew on the project. Grolsch hopes that the brewery will be the most efficient in Europe. To achieve this it is focusing on the total trackability of the process flow and on the production costs for each individual production batch and/or operating shift and/or stock keeping unit. By working on total cost of ownership it is paring down the manning level necessary to operate the line, maintenance time and expenditure, and maximising line availability. It is especially conscious of cutting elctricity, water, heating, and cooling costs.

SIG will supply six packaging lines and auxiliary equipment covering

• Caustic System

• Swing Top Manufacturing Line

• Bottling Line, returnable/non return-able glass bottles, 40,000 bph 0.5 l, Swing Top

• Bottling Line, non-returnable glass bottles, 40,000 bph 0.355 l

• Canning Line, 72,000 cph 0.5 l

• Bottling Line, glass returnable bottles, 60,000 bph 0.3 l, bulk products

• Bottling Line, glass returnable bottles, 60,000 bph 0.3 l, special products.

Innovation

Bacteria clean waste water

An in-house waste water treatment developed by Japanese semicondictor maker Miyagi Oki Electric is to be sold commercially by another Oki Electric subsidiary, Oki Environment Technologies.

The innovative process distributes wastewater to different pipes, according to type, then applies the appropriate bacteria. Bacteria cultivated in concentrated amounts decompose organic substances into water and carbon gas, reducing waste. Treatment tanks are kept at 36degC throughout the year, maximising bacterial activity, using excess heat from air conditioning boilers and other facilities. The new process improves decomposition efficiency by 50%, which enables the company to treat 97% of wastewater internally. This drastically reduces the volume of organic wastewater, and cuts disposal costs. Payback is measured in months: the firm spent 8m yen renovating the treatment facility for the new process, cut its organic wastewater 70% or 1980t/y, saving 35m yen a year in waste disposal consignment costs.

European firms ignore patent information

Most companies in Europe ignore the information in patents and therefore lose an important source of business intelligence and innovation, says a new European Patent Office (EPO) report.

The EPO studied 1904 companies, 443 patent lawyers and 29 universities in 30 European countries, aiming to develop more user friendly patent information services.

“Most companies and particularly SMEs (small and medium enterprises) have no idea what patent information can do for them,” says the report.

Almost all the companies in the study wanted more information on innovation and markets. “Patent information is an unparalleled mine of technical information and business intelligence,” the EPO says. Up to 80% of all applied technical knowledge is said to be exist patent documents, and cannot be found elsewhere.

Generally, companies in the north and west of Europe have better access to patent information. But companies in the Czech Republic, Hungary, Slovenia and Slovakia also enjoy relatively good levels of access, while in Sweden and Liechtenstein access is quite poor, the report says.

Companies that are best equipped to exploit patent information tend to be large, innovation-focused, and to have specific departments for dealing with patenting and intellectual property (IP) issues.

SMEs ignore patent data because they find it inaccessible, difficult to use and expensive, and would like more help to overcome these hurdles. While the Internet makes a good starting point, companies should also use conferences, professional organisations and commercial suppliers.

Obesity

Obesity training wasted on GPs

Training doctors in weight management techniques does not slim their patients, the British Medical Journal reports this week.

Moore and colleagues evaluated the impact of a training programme intended to improve the management of obesity. The study involved 44 general practices (22 completed the training and 22 acted as controls) and 843 obese adult patients. Control practices were asked to provide usual care to their patients.

After 12 months, there was no difference in weight between those patients attending trained practices and controls.

Implementation of obesity management was low and did not achieve improved patient weight loss, say the authors. They suggest other strategies to manage obesity in primary care urgently need to be considered and evaluated. These might include motivated and dedicated obesity specialists, use of leisure services, and use of the commercial weight loss sector.

Research

GSK in seventh R&D heaven

UK-based drugs companies GlaxoSmithKline (GSK) is to create a seventh centre of excellence for drug discovery (CEDD), which will concentrate on biopharmaceuticals, a field where GSK is “progressing a growing number of assets in its early-stage pipeline”. The new unit will start up this year.

Barcodes to get reprieve?

Ink that contains nanoscale magnetic particles could extend the life of barcode technology in the face of the onslaught of radio frequency identification (RFID) technology.

Researchers at the UK’s Durham University described the new anti-counterfeit technology at a conference on nanotechnology in crime prevention and detection in London last week.

The barcode lines contain atoms of an allow of nickel and iron. Each is printed in a similar way to electronic circuits with each printing creating a unique magnetic field. This can be measured, recorded and later checked using polarised laser light against a database to ensure that a barcode is genuine.

Because the printing process distributes the magnetic particles randomly, barcodes with specific magnetic fields cannot be created to order. To beat the system, counterfeiters would have to break into the database. Fraudsters could be disrupted if the barcodes are printed on material that is destroyed if tampered with.

 
Tuesday, 01 February 2005
Events
FishWrap
NumbersGames
PaperChase
Library
Links